Sarah E.M. Herman
- Genetics top 0.5%
- Pathology and Forensic Medicine top 2%
- Molecular Biology top 10%
- Immunology top 10%
- Hematology top 5%
- Co-authors
- Amy J. JohnsonJohn C. ByrdBrian J. LannuttiKamal D. PuriNeill A. GieseSarah MeadowsJeffrey TynerRoger G. Ulrich
- Topics
- Chronic Lymphocytic Leukemia Research (18 papers)Lymphoma Diagnosis and Treatment (9 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)
- Partner nations
- United StatesTaiwanSpain
In The Last Decade
Sarah E.M. Herman
21 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Genetics 1.1k
- Pathology and Forensic Medicine 719
- Molecular Biology 713
- Immunology 423
- Hematology 335
Countries citing papers authored by Sarah E.M. Herman
This map shows the geographic impact of Sarah E.M. Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E.M. Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E.M. Herman more than expected).
Fields of papers citing papers by Sarah E.M. Herman
This network shows the impact of papers produced by Sarah E.M. Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E.M. Herman. The network helps show where Sarah E.M. Herman may publish in the future.
Co-authorship network of co-authors of Sarah E.M. Herman
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E.M. Herman. A scholar is included among the top collaborators of Sarah E.M. Herman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E.M. Herman. Sarah E.M. Herman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 21 | |
| 3 | 56 | |
| 4 | 4 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 131 | |
| 8 | 9 | |
| 9 | 2 | |
| 10 | 29 | |
| 11 | 82 | |
| 12 | 58 | |
| 13 | 40 | |
| 14 | 81 | |
| 15 | 4 | |
| 16 | 7 | |
| 17 | CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viabilitybreakdown → | 588 |
| 18 | 2 | |
| 19 | 3 | |
| 20 | 11 |
About Sarah E.M. Herman
Sarah E.M. Herman is a scholar working on Genetics, Pathology and Forensic Medicine and Physiology, having authored 21 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (9 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Genetics (1.1k citations), Pathology and Forensic Medicine (719 citations) and Hematology (335 citations). Sarah E.M. Herman has collaborated with scholars based in United States, Taiwan and Spain. Frequent co-authors include Amy J. Johnson, John C. Byrd, Brian J. Lannutti, Kamal D. Puri, Neill A. Giese, Sarah Meadows, Jeffrey Tyner, Roger G. Ulrich, Bart Steiner and Adam Kashishian. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.